• About Us
  • Contact Us
  • Advertise
  • Submissions
  • Comment Policy
  • Privacy Policy
  • Disclaimer

DRP Gazette

News From The Wall Street Grapevine
Menu
  • About Us
    • Contact Us
    • Privacy Policy
    • Advertise
    • Comment Policy

Biopharmacy Archive

Sundial Growers (NASDAQ:SNDL) Stock Needs Trigger To Move Up: Here is Why
Biopharmacy, News

Sundial Growers (NASDAQ:SNDL) Stock Needs Trigger To Move Up: Here is Why

July 1, 2021 | Mark McKelvie |
More
Panbela Therapeutics (NASDAQ:PBLA) Stock Sees Heavy Sell-Off: Is It a Good Buy Now?
Biopharmacy, News

Panbela Therapeutics (NASDAQ:PBLA) Stock Sees Heavy Sell-Off: Is It a Good Buy Now?

July 1, 2021 | Ankit Singhania |
More
KiromicBioPharma (KRBP) Stock Plunges After The Stock Offering: A Good Opportunity?
Biopharmacy, News

KiromicBioPharma (KRBP) Stock Plunges After The Stock Offering: A Good Opportunity?

July 1, 2021 | Tim Ormond |
More
VistaGen Therapeutics (VTGN)  Stock Extends Weekly Rally: How Far Can It Go?
Biopharmacy, News

VistaGen Therapeutics (VTGN) Stock Extends Weekly Rally: How Far Can It Go?

July 1, 2021 | Sean Dougherty |
More
VBI Vaccines Inc. (VBIV) Stock Sees Selling Pressure After The Recent Jump
Biopharmacy, News

VBI Vaccines Inc. (VBIV) Stock Sees Selling Pressure After The Recent Jump

July 1, 2021 | Ankit Singhania |
More
Will Obseva SA (NASDAQ:OBSV) Move Back To New Highs After The Consolidation?
Biopharmacy, News

Will Obseva SA (NASDAQ:OBSV) Move Back To New Highs After The Consolidation?

June 30, 2021 | Sean Dougherty |
More
Is CNS Pharmaceuticals (CNSP) Stock Ready To Hit $3 Soon?
Biopharmacy, News

Is CNS Pharmaceuticals (CNSP) Stock Ready To Hit $3 Soon?

June 30, 2021 | Mark McKelvie |
More
Is DiaMedica Therapeutics (DMAC) A Good Buying Opportunity After The Big Fall?
Biopharmacy, News

Is DiaMedica Therapeutics (DMAC) A Good Buying Opportunity After The Big Fall?

June 30, 2021 | Sean Dougherty |
More
MediWound. (MDWD) Stock Takes a Hit: Will It Rebound Soon?
Biopharmacy, News

MediWound. (MDWD) Stock Takes a Hit: Will It Rebound Soon?

June 30, 2021 | Mark McKelvie |
More
Tonix Pharmaceuticals (TNXP) Stock Up 58% YTD: But Why?
Biopharmacy, News

Tonix Pharmaceuticals (TNXP) Stock Up 58% YTD: But Why?

June 30, 2021 | Tim Ormond |
More
Adamis Pharmaceuticals (ADMP) Stock Consolidates After The Big Jump
Biopharmacy, News

Adamis Pharmaceuticals (ADMP) Stock Consolidates After The Big Jump

June 30, 2021 | Sean Dougherty |
More
  • First
  • Previous
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next
  • Last
Copyright © 2025 DRP Gazette Theme by DRP Gazette
  • About Us
  • Advertise
  • Comment Policy
  • Contact Us
  • Disclaimer
  • Maison Luxe Inc (OTCMKTS:MASN) Stock Soars As Company All Set To Acquire Kicks On Demand
  • Privacy Policy
  • Submissions